Intuitive Surgical (NASDAQ:ISRG) Given New $560.00 Price Target at UBS Group

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price objective hoisted by analysts at UBS Group from $500.00 to $560.00 in a report released on Monday. The firm currently has a "neutral" rating on the medical equipment provider's stock. UBS Group's price objective would indicate a potential downside of 2.35% from the company's previous close.

Several other equities analysts have also commented on ISRG. Barclays increased their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday. Truist Financial upped their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research report on Friday. Mizuho lifted their price target on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded down $10.57 during mid-day trading on Monday, hitting $573.48. 2,439,723 shares of the company's stock traded hands, compared to its average volume of 2,025,429. The company has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The company has a fifty day moving average of $547.16 and a 200 day moving average of $505.21. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company's stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Jamie Samath sold 270 shares of the firm's stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock valued at $22,059,506 in the last ninety days. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently bought and sold shares of the company. Massachusetts Financial Services Co. MA purchased a new stake in shares of Intuitive Surgical during the third quarter worth approximately $558,807,000. International Assets Investment Management LLC lifted its holdings in Intuitive Surgical by 49,383.6% in the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. FMR LLC boosted its stake in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider's stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB grew its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after buying an additional 552,058 shares in the last quarter. Finally, State Street Corp raised its position in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider's stock valued at $7,393,673,000 after buying an additional 210,363 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.